Medical Properties Trust (MPW) Upgraded by Zacks Investment Research to “Hold”
Medical Properties Trust (NYSE:MPW) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research note issued to investors on Tuesday.
According to Zacks, “Medical Properties Trust, Inc. is a Birmingham, Alabama based self-advised real estate investment trust formed to capitalize on the changing trends in healthcare delivery by acquiring and developing net-leased healthcare facilities. These facilities include inpatient rehabilitation hospitals, long-term acute care hospitals, regional and community hospitals, women’s and children’s hospitals, skilled nursing facilities, ambulatory surgery centers, and other single-discipline healthcare facilities, such as heart hospitals, orthopedic hospitals and cancer centers. “
Other research analysts also recently issued research reports about the stock. Deutsche Bank downgraded shares of Medical Properties Trust from a “buy” rating to a “hold” rating and dropped their price objective for the company from $14.00 to $13.50 in a research note on Wednesday, January 10th. ValuEngine raised shares of Medical Properties Trust from a “hold” rating to a “buy” rating in a research note on Monday, October 2nd. JPMorgan Chase & Co. raised shares of Medical Properties Trust from an “underweight” rating to a “neutral” rating and set a $14.50 price objective for the company in a research note on Friday, December 15th. Robert W. Baird downgraded shares of Medical Properties Trust from an “outperform” rating to a “neutral” rating and dropped their price objective for the company from $15.00 to $13.00 in a research note on Friday, January 5th. Finally, SunTrust Banks reaffirmed a “buy” rating and set a $15.00 price objective on shares of Medical Properties Trust in a research note on Friday, November 3rd. Eight equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. The stock presently has an average rating of “Hold” and an average price target of $14.30.
Medical Properties Trust (NYSE MPW) opened at $12.76 on Tuesday. Medical Properties Trust has a one year low of $11.90 and a one year high of $14.22. The firm has a market cap of $4,646.63, a PE ratio of 16.79, a P/E/G ratio of 1.57 and a beta of 0.96. The company has a quick ratio of 2.55, a current ratio of 2.55 and a debt-to-equity ratio of 1.26.
Medical Properties Trust (NYSE:MPW) last announced its earnings results on Thursday, November 2nd. The real estate investment trust reported $0.33 earnings per share for the quarter, beating the consensus estimate of $0.32 by $0.01. Medical Properties Trust had a net margin of 39.95% and a return on equity of 7.36%. The firm had revenue of $176.60 million during the quarter, compared to the consensus estimate of $172.57 million. During the same quarter in the previous year, the company posted $0.30 EPS. The firm’s revenue for the quarter was up 39.5% on a year-over-year basis. equities analysts expect that Medical Properties Trust will post 1.33 earnings per share for the current fiscal year.
Institutional investors and hedge funds have recently bought and sold shares of the stock. Ffcm LLC acquired a new stake in Medical Properties Trust during the 3rd quarter worth approximately $116,000. Janus Henderson Group PLC acquired a new stake in Medical Properties Trust during the 2nd quarter worth approximately $136,000. Mcmillion Capital Management Inc. acquired a new stake in Medical Properties Trust during the 3rd quarter worth approximately $137,000. Investors Asset Management of Georgia Inc. GA ADV acquired a new stake in Medical Properties Trust during the 4th quarter worth approximately $138,000. Finally, Cetera Investment Advisers acquired a new stake in Medical Properties Trust during the 2nd quarter worth approximately $141,000. 81.20% of the stock is owned by hedge funds and other institutional investors.
Medical Properties Trust Company Profile
Medical Properties Trust, Inc is a real estate investment trust (REIT). The Company focuses on investing in and owning net-leased healthcare facilities across the United States and selectively in foreign jurisdictions. The Company’s segment is its investments in healthcare real estate, including mortgage and other loans, as well as any equity investments in its tenants.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Medical Properties Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Properties Trust and related companies with Analyst Ratings Network's FREE daily email newsletter.